Success Stories: NIW Status Confirmed without RFE for a Pediatric Resident in Immunology from D.C., Credit to Our Team of Experts

Client’s Testimonial:

“Thank you so much! I really appreciate all your help!”

On April 22^nd, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Pediatric Resident in the Field of Immunology (Approval Notice).

General Field: Immunology

Position at the Time of Case Filing: Pediatric Resident

Country of Origin: Bosnia and Herzegovina

State of Residence at the Time of Filing: District of Columbia

Approval Notice Date: April 22^nd, 2022

Processing Time: 19 months, 21 days

Case Summary:

The I-140 EB2-NIW or National Interest Waiver is one of the many visa types designed for individuals whose work is of national interest to the United States. Thus when an M.D. in Immunology came to our firm for her NIW filing, we made sure to aid her case the best we could. This meant a thorough search of her academic and professional documents for use in her petition. This yielded the following data:

We gave a detailed description of her proposed endeavor and showed that she is an expert in the field of immunology, and her proposed endeavor is to work on utilizing immunological and molecular biology techniques to develop inclusive and effective T-cell therapies.
She wants to improve the outcomes of patients suffering from high-risk solid tumor cancer, hematologic malignancies, and post-transplant viral infections.
We said that her research advancing her proposed endeavor is of great importance because it supports the creation of comprehensive and effective treatments for viral and cancer patients who have exhibited poor responses to conventional therapeutics, including chemotherapy, surgery, and radiation.
Therefore, her research efforts are extremely valuable for patients who are suffering from severe cases of either solid tumor or hematologic cancer as well as associated viral complications. We said that her work to treat viral complications from hematopoietic stem cell transplantations (HSCTs) also holds particular salience for the United States.
Finally, her research has also been financially supported by numerous government institutions that specialize in medical research such as the National Cancer Institute, the National Heart, Lung, and Blood Institute, and the National Center for Advancing Translational Studies.
Furthermore, her work has been an integral facet of six different clinical trials, and she has also shared her research methodologies and techniques through a provisional patent application.
Her research has also resulted in 2 peer-reviewed journal articles and 9 peer-reviewed abstracts (3 first-authored).
Her publications have also been cited a total of 260 times according to Google Scholar, showing the worth of her work for her peers.
Finally, she had also received letters from 4 experts who supported her claim to the category by saying that her work was of great significance for the United States.

So, when her approval came through, we were not surprised. Even though there was an initial delay in her approval, we finally received it in April 2022 without an RFE. We thank our client for her patience and trust. And we wish her the very best for future endeavors.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.